A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals for ...
Actress and hands-on mom Judy Ann Santos, together with her mother, Mommy Carol, headlines the campaign—underscoring the multi-generational trust in TGP Generics. TGP reminds Filipinos why it remains ...
Two-time cancer survivor Sherman McDaniel may be in fragile health, but she is sticking to her vow: “I’m not going anywhere until Generic Theater has a permanent home. Until then, I will not die.” ...
Eli Lilly's market share in India's weight‑loss drug market fell to 56% in March from 61% in February. Novo Nordisk's market share remained steady at 25%. Indian generic drugmakers have launched 26 ...
Multiple dapagliflozin generic approvals are expected to intensify near-term market competition, requiring manufacturers to coordinate production readiness, launch timing, and labeling compliance ...
Dapagliflozin tablets are indicated to reduce the risk of hospitalization for heart failure in adults with type 2 diabetes. Clobetasol propionate foam is indicated for the treatment of moderate to ...
John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. Lizzy Lawrence leads STAT’s ...
The rapid entry of semaglutide generics is beginning to weigh on the growth of Eli Lilly’s tirzepatide brand Mounjaro, even as the broader market expands, data from pharma market intelligence and data ...
Hosted on MSN
Trump's Pharma Tariff Threat Could Hit Indian Generics – But Will It Stick? SEBI RAs Weigh In
Indian pharmaceutical stocks traded under pressure on Wednesday after US President Donald Trump said he would sharply raise tariffs on imported medicines. In an interview with CNBC, he said he would ...
The Democratic Party continues to lead over Republicans in the battle to control the House of Representatives, but by a slimmer margin than two months ago. The latest Rasmussen Reports national ...
The Rasmussen Reports daily Presidential Tracking Poll for Wednesday shows that 44% of Likely U.S. Voters approve of President Trump’s job performance. Fifty-four (54%) disapprove. The latest figures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results